NIH Blueprint empowers drug development for nervous system disorders

First awards will fund 7 teams across the country

The National Institutes of Health has made awards to investigators across the United States for an ambitious set of projects seeking to develop new drugs for disorders of the nervous system.

The projects – aimed at treating conditions such as vision loss, neurodegenerative disease and depression – are funded through the NIH Blueprint for Neuroscience Research. The NIH Blueprint pulls together 15 of the agency's institutes and centers, leveraging their resources to confront major, cross-cutting challenges in neuroscience research. The Blueprint Neurotherapeutics Network (www.neuroscienceblueprint.nih.gov/bpdrugs/index.htm) will serve as a resource enabling investigators to develop new drugs for nervous system disorders and prepare them for clinical trials, and will be funded at up to $50 million over five years.

For decades, public funding from NIH has helped academic labs and small businesses use their ingenuity to pursue new strategies for treating nervous system disorders. However, many labs often lack the resources – time, money, scientific staff, and regulatory expertise – to turn a promising strategy into an effective treatment. The new initiative places these investigators at the helm of an expert drug development team that includes pharmaceutical industry consultants and service contractors.
Read more:

http://www.eurekalert.org/pub_releas...-nbe081811.php